PRF Technologies Ltd. (PRFX) stock
Close on Nov 11, 2026Market cap $617.56KP/E –Yield –
PRF Technologies Ltd. reported revenue of $17.00K for fiscal 2025. Free cash flow was -$3.96M. At the latest close the market valued the company at $617.56K.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $617.56K
- P/E ratio
- –
- Price to sales
- 36.33
- Price to book
- 0.04
- Dividend yield
- –
- Free cash flow yield
- -640.75%
Fundamentals
- Revenue
- $17.00K
- Net income
- -$5.02M
- EPS, diluted
- -$7.47
- Free cash flow
- -$3.96M
Trading
- Previous close
- $0.80
- Open
- $0.82
- Day's range
- $0.67 – $0.82
- Volume
- 28,909
- Average volume (20 days)
- 246,304
- Beta (5 years)
- 1.61
- 52-week range
- $0.64 – $7.95
- RSI (14 days)
- 43.6
- Volatility (1 year)
- 179.6%
- Relative volume
- 0.11×
- WACC
- 12.9%
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | PRFX | S&P 500 | Difference | PRFX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -15.4% | -2.4% | −13.0 pts | ||
| 3 months | -32.4% | -1.2% | −31.3 pts | ||
| Year to date | -76.8% | +12.3% | −89.1 pts | ||
| 1 year | -83.2% | +12.4% | −95.7 pts | ||
| 3 years | -98.8% | +78.8% | −177.6 pts | -76.9% | +21.4% |
| 5 years | -99.9% | +75.2% | −175.1 pts | -74.8% | +11.9% |
Nine years at a glance
Fiscal years 2017 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases PRF Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About PRF Technologies
Pharmaceutical Preparations
PRF Technologies Ltd., previously known as PainReform, operates in clinical pharmaceutical development and solar artificial intelligence software. Through its drug development operations, the company works on advancing therapeutic candidates such as OcuRing-K and PRF-110, alongside biopharmaceutical assets acquired through Layerbio, Inc. In its technology segment, the company commercializes the DeepSolar AI software platform, which delivers analytics and automated solutions for solar energy systems. Its target customers comprise participants within the renewable solar energy industry as well as prospective healthcare patients and providers.
Company profile, executives and historyPRF Technologies stock: common questions
What is PRF Technologies's stock price?
PRFX closed at $0.74 on Nov 11, 2026, down 6.69% on the day. Over the past 52 weeks it traded between $0.64 and $7.95.
What is PRF Technologies's market cap?
PRF Technologies was worth $617.56K at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is PRFX's P/E ratio?
PRF Technologies lost money over fiscal 2025 (diluted EPS -$7.47), so it has no meaningful P/E ratio.
How much revenue does PRF Technologies make?
PRF Technologies reported revenue of $17.00K for fiscal 2025.
Does PRF Technologies pay a dividend?
No. PRF Technologies has not paid a cash dividend over the last twelve months.
How has PRFX stock performed over the past year?
Including dividends, PRFX returned -83.2% over the past year, against +12.4% for the S&P 500.
How many PRFX shares are sold short?
0M shares were sold short at the latest FINRA report, 2.03% of the float, or 1.0 days of average trading volume.
Who are PRF Technologies's competitors?
Companies most similar to PRF Technologies by business, industry and size include KPRX, JUNS, KZIA, ADXN, CNBX.
See a number that looks wrong?